Drug Use Study of Febuxostat After Recent Changes in the Prescribing Information

Completed

Conditions studied: Gout, Cardiovascular Diseases

In brief

The prescribing information provides information on medicines. This study will check the number of patients starting febuxostat and the number of febuxostat users with cardiovascular disease after changes to the prescribing information.

Key facts

Study ID

NCT04853160

Run by

Takeda

People needed

24046

Starts

2020-08-15

Expected to finish

2021-01-05

Last updated by the study team

2021-04-27

Who can join

Age: 21 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Index fill date on or after 01 June 2016.
• Having at least one diagnosis for gout (identified with diagnosis codes, International Classification of Diseases, clinical modification, ninth revision [ICD-9-CM]: 274.x or International Classification of Diseases, tenth revision [ICD-10]: M10.x) at any time in the participant's record.
• Continuously enrolled for at least 12 months prior to index fill date.

Where it is running

• Central Contact — Cambridge, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.